Want to join the conversation?
$BAX's gross margin for 2015 fell to 41.6% from 42.7% last year. In addition to the unfavorable impact of the special items, gross margin in 2015 was unfavorably impacted by decreased sales of cyclophosphamide within the Hospital Products segment, partially offset by improved product mix in the Renal segment.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!
$SGY is expected to achieve $6.17 price target in next year, with a minimum target of $3.00, due to the price increase of 27.85% to $6.29 during the last trading session.
$SWHC showing consistent increase in sales for the past three quarters suggesting the US craze for firearms is not going to subside soon.